## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-25T18:23:19.740Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Science 37 Clinical Research" developer_entity: "Science 37" bundle_id: "com.science37.mobile" app_store_id: "1505694717" category: "Health & Fitness" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2025-10-31" report_date: "2026-05-25" last_verified: "2026-05-25" report_version: "3.45.1" total_reviews: 165 overall_rating: 3.58 sentiment: "Mixed" sentiment_score: 65 confidence: "medium" confidence_score: 0.75 top_praise_theme: "Convenience of remote participation" top_complaint_theme: "Technical friction during assessment tasks" review_sample_size: 53 data_age_days: 0 momentum_velocity: "maintenance" intelligence_version: 3 competitor_count: 6 tags: ["health & fitness", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "clinical", "trial", "participants"] canonical_url: "https://marlvel.ai/intel-report/health-fitness/science-37-clinical-research" license: "CC-BY-NC 4.0" content_version: "v2" --- # Science 37 Clinical Research App Audit ## TL;DR {#tldr} - **Category**: Health & Fitness · Free - **Signal**: Rating 3.58 · Sentiment Mixed - **Recent focus**: Technical friction during assessment tasks (top complaint) · Convenience of remote participation (top praise) > **TL;DR:** Science 37 Clinical Research is a health & fitness app by Science 37, rated 3.58/5 by 165 users, with Mixed user sentiment (65/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Science 37 Clinical Research shows Mixed sentiment (3.58/5 from 165 reviews) — users praise convenience of remote participation but report issues with technical friction during assessment tasks. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 3.58/5 (165 reviews) | | **User Mood** | Mixed | | **Category** | Health & Fitness | | **Developer** | Science 37 | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.75/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Science 37 - **Category:** Health & Fitness - **Target Audience:** Clinical trial participants requiring remote access to study procedures and pharmaceutical sponsors seeking decentralized trial solutions. - **Platforms:** iOS & Android - **Version Audited:** 3.45.1 - **Audit Date:** 2026-05-25 - **Signal Count:** 53 reviews analyzed - **Confidence:** Medium (0.75/1.0) - **App Store ID (iOS):** 1505694717 - **Bundle ID:** com.science37.mobile - **Google Play ID:** com.science37.mobile - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-05-25 ## Executive Snapshot **What it is:** Science 37 is a clinical research participant app for iOS and Android that enables remote trial assessments and study team communication. **Why users hire it:** Users hire the app to complete mandatory clinical trial tasks from home, replacing the need for travel to physical research sites. ## App DNA (Features & Intent) - **[Differentiator] Direct-to-Patient Site:** Centralized platform for clinical trial participation, including remote assessments and study documentation. - **[Differentiator] Research-Grade Nursing Network:** Access to a network of 150+ trained nurses for home-based clinical procedures. * *User Intent:* Users want to quickly find relevant content or features. ## Market Position {#market-position} Science 37 maintains a specialized niche in the Health & Fitness category, with a 3.67 average rating across 165 total ratings. The platform's focus on decentralized clinical trials differentiates it from general wellness apps, though it lacks the high-frequency engagement metrics of broader medical portals. ## Monetization Strategy - **Model:** Free - **Tiers:** Free app for study participants - **Analysis:** The app functions as a free utility for trial participants, with monetization occurring via B2B service contracts with pharmaceutical sponsors. ## 🟡 User Sentiment (Medium Confidence: 165 reviews) {#user-sentiment} - **Overall Rating:** 3.58/5 - **Platform Split:** iOS 3.8/5 (27 ratings) | Android 3.5/5 (138 ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Convenience of remote participation** ### Top Complaints (Impact Areas) - **Technical friction during assessment tasks** ## SWOT Analysis {#swot} **Core Strengths:** - 150+ research-grade nursing network enables decentralized trial execution - Centralized platform architecture supports complex longitudinal data collection **Critical Frictions:** - 0.28 rating gap between iOS and Android platforms - No wearable integration for passive data collection - Manual assessment-heavy interface increases user friction **Growth Levers:** - Integrate wearable sensor data to automate manual assessments - Expand B2B partnerships into broader patient-management services **Market Threats:** - Wearable-first health monitoring apps displacing manual data entry - High-cadence medical portals capturing patient attention via daily-use modules ## Recent Changes (v2 → v3) {#recent-changes} The platform is pivoting its strategic focus toward wearable integration to counter manual-entry friction, while showing a slight improvement in user rating. **Overall trend**: Mixed **Compared at**: 2026-05-25 ### High-impact changes - **[Improved] Rating and Sentiment Shift** (sentiment) — Average rating increased from 3.53 to 3.67, and overall sentiment classification shifted from 'terrible' to 'mixed'. - **[Added] Wearable Integration Gap** (swot) — Added 'No wearable integration for passive data collection' as a weakness and 'Wearable-first health monitoring apps' as a threat. ### Medium-impact changes - **[Added] Platform Parity Weakness** (swot) — Added '0.28 rating gap between iOS and Android platforms' as a specific weakness in the SWOT analysis. - **[Shifted] Strategic Focus Pivot** (positioning) — Executive summary narrative shifted from focusing on general technical instability to the specific need for wearable-first data collection to reduce manual friction. ## What's New - **Latest (v3.45.1, 6 months ago):** General bug fixes and performance optimizations. ## App Momentum (Maintenance) {#momentum} - Maintains stable core trial functionality. - Ships periodic stability updates. > **Cadence:** 2 total versions · 0 majors in last 6 months · 206 days since last update · 2 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Science 37 Clinical Research is an established health & fitness app that is completely free. With a 3.58/5 rating from 165 reviews, it shows polarized user reception. > **Bottom Line:** Science 37 holds a unique position in decentralized trials through its nursing network, but the manual-heavy interface creates churn risk against wearable-first competitors, so the PM must prioritize passive data integration to secure long-term participant retention. **Best for:** Clinical trial participants requiring remote access to study procedures and pharmaceutical sponsors seeking decentralized trial solutions. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] [MEDIUM IMPACT] Audit Android stability because of the 0.28 rating gap vs iOS → improve platform parity — *The rating delta between platforms indicates significant Android-specific technical friction.* _(trade-off: deprioritize Pause new feature development for the nursing network dashboard — stability is the current retention priority.)_ - [ ] [INVEST] [HIGH IMPACT] Ship wearable integration for passive data collection because manual assessment friction is the top complaint → reduce user churn — *Competitors like Endel and Gluroo leverage passive data, exposing Science 37's manual-only interface as a competitive weakness.* _(trade-off: deprioritize Deprioritize the UI refresh of the study documentation module — wearable data has higher impact on participant retention.)_ ### Feature Gaps vs Competitors - Wearable-first data collection (available in Endel and Gluroo but absent here) - Daily-use health modules (available in Portal Pacjenta CMP but absent here) ### Outlook: Mixed The decentralized clinical trial market is shifting toward automated, wearable-first data collection to reduce participant burden. Science 37's current manual-only assessment model leaves it exposed to competitors that offer more passive and integrated patient experiences, so the platform must pivot to wearable support to maintain its B2B value proposition. - 🔴 The Android rating gap persists, indicating that technical debt in the latest release is eroding the user experience for the majority base. - ⚪ Recent updates focus on stability rather than feature expansion, suggesting the platform is in a maintenance phase rather than active growth. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 3.58/5 | | Total Reviews | 165 | | Sentiment | Mixed (65/100) | | Confidence | Medium | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 2 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Science 37 Clinical Research** (this app) | 3.58/5 | Mixed | Science 37 | | [Portal Pacjenta CMP](https://marlvel.ai/intel-report/medical/com-cmp-patientportal) | 4.8/5 | N/A | Centrum Medyczne CMP | | [Endel Rituals](https://marlvel.ai/intel-report/health-fitness/endel-rituals) | 4.8/5 | Excited | Endel | | [TruHearing App](https://marlvel.ai/intel-report/medical/truhearing-app) | 4.2/5 | N/A | Sivantos Pte. Ltd. | | [myRemote App](https://marlvel.ai/intel-report/medical/myremote-app) | 3.7/5 | N/A | Sivantos Pte. Ltd. | | [GotCGM Watchface Digital](https://marlvel.ai/intel-report/health-fitness/gotcgm-watchface-digital) | N/A/5 | N/A | Gluroo Imaginations Inc. | ## Company Profile - **Developer:** Science 37 - **Website:** [https://www.science37.com](https://www.science37.com) - **Social:** [LinkedIn](https://www.linkedin.com/company/science-37) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/science-37-clinical-research/id1505694717?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.science37.mobile&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.science37.com) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Portal Pacjenta CMP*](https://marlvel.ai/intel-report/medical/com-cmp-patientportal) (Centrum Medyczne CMP) — 4.8/5 Rating | N/A Sentiment - [*Endel Rituals*](https://marlvel.ai/intel-report/health-fitness/endel-rituals) (Endel) — 4.8/5 Rating | Positive Sentiment - [*TruHearing App*](https://marlvel.ai/intel-report/medical/truhearing-app) (Sivantos Pte. Ltd.) — 4.2/5 Rating | N/A Sentiment - [*myRemote App*](https://marlvel.ai/intel-report/medical/myremote-app) (Sivantos Pte. Ltd.) — 3.7/5 Rating | N/A Sentiment - [*GotCGM Watchface Digital*](https://marlvel.ai/intel-report/health-fitness/gotcgm-watchface-digital) (Gluroo Imaginations Inc.) — N/A Rating | N/A Sentiment - [*Alinare: Calm Interior*](https://marlvel.ai/intel-report/health-fitness/alinare-calm-interior) (SPIDER SERVICE SRL) — N/A Rating | N/A Sentiment - [*Taller AI: Height Maximizer*](https://marlvel.ai/intel-report/health-fitness/taller-ai-height-maximizer) (Leadimize) — 4.7/5 Rating | N/A Sentiment - [*GoTall - Height Predictor*](https://marlvel.ai/intel-report/health-fitness/gotall-height-predictor) (Super Viral Studio) — 4.6/5 Rating | N/A Sentiment - [*TallerTeen - Grow Taller Now*](https://marlvel.ai/intel-report/health-fitness/tallerteen-grow-taller-now) (Viral App Developement LLC) — 4.7/5 Rating | Positive Sentiment - [*Strava: Run, Bike, Walk*](https://marlvel.ai/intel-report/health-fitness/strava-run-bike-walk) (Strava, Inc.) — 4.7/5 Rating | Mixed Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.75/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 53 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/health-fitness/science-37-clinical-research) Data licensed for AI Agent attribution under CC-BY-NC 4.0.